Knockdown of Muscle-Specific Ribosomal Protein L3-Like Enhances Muscle Function in Healthy and Dystrophic Mice

Abstract

Ribosomal protein L3-like (RPL3L) is a poorly characterized ribosomal protein that is exclusively expressed in skeletal and cardiac muscle. RPL3L is also downregulated in Duchenne muscular dystrophy (DMD), suggesting that it may play an important role in muscle biology. In this study, we investigated the role of RPL3L in skeletal muscle of healthy C57 and dystrophic mdx mice. We show that RPL3L is developmentally regulated and that intramuscular adeno-associated virus (AAV)-mediated RPL3L knockdown in the tibialis anterior of C57 and mdx mice results in increased specific force with improved resistance to eccentric contraction induced muscle damage in dystrophic muscles. The mechanism by which RPL3L knockdown improves muscle function remains unclear. Histological observations showed a significant increase in muscle length and decrease in muscle cross-sectional area after RPL3L inhibition suggesting that this ribosomal protein may play a role in myofiber morphology. The endogenous downregulation of RPL3L in DMD may be a protective mechanism that attempts to improve skeletal muscle function and counteract the dystrophic phenotype.

Get full access to this article

View all access options for this article.

References

Van Raay

, Connors

, Klinger

, Landes

and Burn

. (1996). A novel ribosomal protein L3-like gene (RPL3L) maps to the autosomal dominant polycystic kidney disease gene region. Genomics, 37:172–176.

Schulze

and Nierhaus

. (1982). Minimal set of ribosomal components for reconstitution of the peptidyltransferase activity. EMBO J, 1:609–613.

Venema

and Tollervey

. (1999). Ribosome synthesis in Saccharomyces cerevisiae. Annu Rev Genet, 33:261–311.

Thorrez

, Van Deun

, Tranchevent

, Van Lommel

, Engelen

, Marchal

, Moreau

, Van Mechelen

and Schuit.

(2008). Using ribosomal protein genes as reference: a tale of caution. PLoS One, 3:e1854.

Gupta

and Warner

. (2014). Ribosome-omics of the human ribosome. RNA, 20:1004–1013.

Ganapathi

, Argyriou

, Martinez-Azorin

, Morlot

, Yigit

, Lee

, Auber

, von Gise

, Petrey

, et al. (2020). Bi-allelic missense disease-causing variants in RPL3L associate neonatal dilated cardiomyopathy with muscle-specific ribosome biogenesis. Hum Genet, 139:1443–1454.

Chaillou

, Zhang

and McCarthy

. (2016). Expression of muscle-specific ribosomal protein L3-like impairs myotube growth. J Cell Physiol, 231:1894–1902.

Chen

, Zhao

, Borup

and Hoffman

. (2000). Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol, 151:1321–1336.

Haslett

, Sanoudou

, Kho

, Bennett

, Greenberg

, Kohane

, Beggs

and Kunkel

. (2002). Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci U S A, 99:15000–15005.

10.

Seno

, Trollet

, Athanasopoulos

, Graham

, Hu

and Dickson.

(2010). Transcriptomic analysis of dystrophin RNAi knockdown reveals a central role for dystrophin in muscle differentiation and contractile apparatus organization. BMC Genomics, 11:345.

11.

Mendell

and Lloyd-Puryear

. (2013). Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy. Muscle Nerve, 48:21–26.

12.

Gumerson

and Michele

. (2011). The dystrophin-glycoprotein complex in the prevention of muscle damage. J Biomed Biotechnol, 2011:210797.

13.

Matsumura

, Ohlendieck

, Ionasescu

, Tome

, Nonaka

, Burghes

, Mora

, Kaplan

, Fardeau

and Campbell

. (1993). The role of the dystrophin-glycoprotein complex in the molecular pathogenesis of muscular dystrophies. Neuromuscul Disord, 3:533–535.

14.

Duan

. (2018). Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy. Mol Ther, 26:2337–2356.

15.

Malerba

, Klein

, Bachtarzi

, Jarmin

, Cordova

, Ferry

, Strings

, Espinoza

, Mamchaoui

, et al. (2017). PABPN1 gene therapy for oculopharyngeal muscular dystrophy. Nat Commun, 8:14848.

16.

Lu-Nguyen

, Ferry

, Schnell

, Hanson

, Popplewell

, Dickson

and Malerba

. (2019). Functional muscle recovery following dystrophin and myostatin exon splice modulation in aged mdx mice. Hum Mol Genet, 28:3091–3100.

17.

Mayeuf-Louchart

, Hardy

, Thorel

, Roux

, Gueniot

, Briand

, Mazeraud

, Bougle

, Shorte

, et al. (2018). MuscleJ: a high-content analysis method to study skeletal muscle with a new Fiji tool. Skelet Muscle, 8:25.

18.

Head

, Williams

and Stephenson

. (1992). Abnormalities in structure and function of limb skeletal muscle fibres of dystrophic mdx mice. Proc Biol Sci, 248:163–169.

19.

Moens

, Baatsen

and Marechal

. (1993). Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J Muscle Res Cell Motil, 14:446–451.

20.

Lee SJ. (2004). Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol, 20:61–86.

21.

Mariot

, Joubert

, Hourde

, Feasson

, Hanna

, Muntoni

, Maisonobe

, Servais

, Bogni

, et al. (2017). Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches. Nat Commun, 8:1859.

22.

Lu-Nguyen

, Dickson

and Malerba

. (2018). Systemic intravenous administration of antisense therapeutics for combinatorial dystrophin and myostatin exon splice modulation. Methods Mol Biol, 1828:343–354.

23.

Lu-Nguyen

, Malerba

, Popplewell

, Schnell

, Hanson

and Dickson

. (2017). Systemic antisense therapeutics for dystrophin and myostatin exon splice modulation improve muscle pathology of adult mdx mice. Mol Ther Nucleic Acids, 6:15–28.

24.

Malerba

, Kang

, McClorey

, Saleh

, Popplewell

, Gait

, Wood

and Dickson.

(2012). Dual myostatin and dystrophin exon skipping by morpholino nucleic acid oligomers conjugated to a cell-penetrating peptide is a promising therapeutic strategy for the treatment of Duchenne muscular dystrophy. Mol Ther Nucleic Acids, 1:e62.

25.

Tonino

, Kiss

, Strom

, Methawasin

, Smith

, 3rd, Kolb

, Labeit

and Granzier.

(2017). The giant protein titin regulates the length of the striated muscle thick filament. Nat Commun, 8:1041.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.28 MB

0.49 MB

1.72 MB